Do Cancer Stem Cells have an Immunomodulatory Role Different from the Bulk of Tumor Cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of carcinogenesis & mutagenesis

• Publication date

  2013-05-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4172/2157-2518.S14-003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

  2013cited by this paper
• A restricted cell population propagates glioblastoma growth after chemotherapy

  2012cited by this paper
• Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas

  2012cited by this paper
• Cancer: Resolving the stem-cell debate

  2012cited by this paper
• Defining the mode of tumour growth by clonal analysis

  2012cited by this paper
• The role of cancer stem cells in relapse of solid tumors.

  2012cited by this paper
• Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells.

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules

  2011cited by this paper
• The roles of fascins in health and disease

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells.

  2011cited by this paper
• Migrastatin analogues target fascin to block tumour metastasis

  2011cited by this paper
• Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.

  2011cited by this paper
• Migrastatin Analogues Target Fascin to Block Tumor Metastasis

  2010cited by this paper
• Modulation of T-cell activation by malignant melanoma initiating cells.

  2010cited by this paper
• The PD‐1 pathway in tolerance and autoimmunity

  2010cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

  2010cited by this paper
• Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

  2010cited by this paper
• Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β

  2010cited by this paper
• Cancer vaccines and immunotherapy

  2009cited by this paper
• Cancer stem cells: mirage or reality?

  2009cited by this paper
• Antitumor Immunity and Cancer Stem Cells

  2009cited by this paper
• Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Stem Cell Niche, the Microenvironment and Immunological Crosstalk

  2008cited by this paper
• Identification of cells initiating human melanomas

  2008cited by this paper
• FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

  2008cited by this paper
• Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

  2008cited by this paper
• Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment

  2007cited by this paper
• The B7 Family and Cancer Therapy: Costimulation and Coinhibition

  2007influential reference
• Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell.

  2007cited by this paper
• A Link between PDL1 and T Regulatory Cells in Fetomaternal Tolerance1

  2007influential reference
• Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells

  2007cited by this paper
• Immunomodulation by mesenchymal stem cells and clinical experience

  2007cited by this paper
• Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance

  2007cited by this paper
• T-cell apoptosis in human glioblastoma multiforme: implications for immunotherapy.

  2006cited by this paper
• Malignant melanoma: genetics and therapeutics in the genomic era.

  2006cited by this paper
• Metastatic breast cancer: an updating.

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Molecular Imaging of Human Embryonic Stem Cells: Keeping an Eye on Differentiation, Tumorigenicity and Immunogenicity

  2006cited by this paper
• An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

  2006influential reference
• Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells

  2006cited by this paper
• Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

  2005influential reference
• Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.

  2005cited by this paper
• ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.

  2005cited by this paper
• Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium

  2005cited by this paper
• Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?

  2005cited by this paper
• Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.

  2004influential reference
• Self-renewal and solid tumor stem cells

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004influential reference
• Cancer Statistics, 2004

  2004cited by this paper
• Human Embryonic Stem Cells Possess Immune‐Privileged Properties

  2004cited by this paper
• Glioblastoma Multiforme and Anaplastic Astrocytoma

  2003cited by this paper
• Pluripotent bone marrow cells in leukemic mice elicit enhanced immune reactivity following sheep erythrocyte administration in-vivo. A possible S-LFA3 interactive immunotherapy.

  2003cited by this paper
• Pluripotent bone marrow cells in leukemic mice elicit enhanced immune reactivity following sheep erythrocyte administration in-vivo. A possible S-LFA3 interactive immunotherapy.

  2003cited by this paper
• Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

  2002cited by this paper
• Interleukin-1--a major pleiotropic cytokine in tumor-host interactions.

  2002cited by this paper
• Fascin Is Involved in the Antigen Presentation Activity of Mature Dendritic Cells1

  2001cited by this paper
• A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

  2001cited by this paper
• Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach.

  2001cited by this paper
• Cutting Edge: The Dendritic Cell Cytoskeleton Is Critical for the Formation of the Immunological Synapse1

  2001cited by this paper
• The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells.

  1998cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper
• Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction

  1989cited by this paper
• Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications

  1985cited by this paper

• Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes

  2021cites this paper
• PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis

  2020cites this paper
• Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.

  2020cites this paper
• Targeting cancer stem cells in the clinic: Current status and perspectives.

  2018cites this paper
• Exploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remission

  2018cites this paper
• Cancer stem cells and tumor immunoediting: putting two and two together

  2016cites this paper
• The quintessential quiescence of cancer stem cells: a struggle towards better treatment

  2016cites this paper
• Stem Cells and Cancer

  2016cites this paper
• IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process

  2016cites this paper
• A Systemic Review of Clinical Trials on Dendritic-Cells Based VaccineAgainst Malignant Glioma

  2015cites this paper
• Stem cells and its importance in Therapies

  2015cites this paper
• Cancer Diagnosis, Treatment and Therapy

  2013cites this paper